Satellite Symposia

DAY 1: Thursday, July 7, 2016

National Psoriasis Foundation Symposium

"Complex cases in psoriasis"

10:00 - 11:30 - Room 251


Jeffrey Weinberg, MD
Mount Sinai School of Medicine
New York, NY, USA 


1. Interactive Presentation (~30 minutes)
• Commonalities in the pathophysiology of psoriasis and comorbid conditions
• Integrating techniques, technologies and tools that support earlier recognition and aggressive treatment of psoriasis and psoriatic arthritis
• Safety, efficacy and the role of current systemic psoriasis treatments in addressing skin, joint and cardiometabolic symptoms in patients with complex presentations
• Review of emerging drugs
• Applying a patient-centric approach to pursuing treatment goals in patients with complex psoriasis presentations

2. Complex Cases (~45 minutes)
• Complex patient 1: Patient who has failed previous biologic therapy
• Complex patient 2: Woman of child‑bearing age
• Complex patient 3: Patient with cardiovascular comorbidities
• Complex patient 4: Immunocompromised patient

3. Summary, Conclusions and Q&A (~15 minutes)

DAY 2: Friday, July 8, 2016

Abbvie Symposium

"PsOACT: A lifetime of comprehensive and personalized psoriasis care”

12:45 - 14:15 - Room 252AB


Professor Kristian Reich (Germany)


Professor Wolf-Henning Boehncke (Switzerland)
Professor Matthias Augustin (Germany)


Welcome and introduction – Kristian Reich (Hamburg, Germany)
Achieving a patient-focused approach to care – Matthias Augustin (Hamburg, Germany)
Creating lifelong personalized care – Kristian Reich (Hamburg, Germany)
Taking a comprehensive approach to manage psoriasis – Wolf-Henning Boehncke (Geneva, Switzerland)
Discussion and audience Q&A

Janssen Pearls Symposium

"Cognitive consequences: understanding the link between psoriasis and psychiatric comorbidities"

12:45 - 14:15 - Amphitheatre Bleu


1. Welcome and introduction - Professor Peter van de Kerkhof 
2. The complexity of psoriasis: a systemic disease - Professor Peter van de Kerkhof
3. Risk factors for cognitive impairment in patients with psoriasis - Professor Paolo Gisondi
4. Alexithymia and the burden of psoriasis: outcomes from the EPIDEPSO study - Professor Carle Paul
5. Questions and closing remarks - All

A Medscape Education Symposium*

"Il-17a and Psoriasis Management : State of the Art"

12:45 - 14:15 - Room Maillot

Craig Leonardi, MD (Chair)
Clinical Professor of Dermatology, St. Louis
University Medical School,


Denis Jullien, MD, PhD
Professor, Department of Dermatology at Hôpital Edouard Herriot,
Université Claude Bernard
Lyon, France

Richard Langley, MD, FRCPC
Professor, Department of Medicine, Division of Clinical Dermatology & Cutaneous Science, Dalhousie
University, Halifax, Nova Scotia

Ulrich Mrowietz, MD
Head of Psoriasis-Center,
Dept. of Dermatology, Venerology and Allergology, University Medical Center
Campus Kiel, Germany


Craig Leonardi, MD

Psoriasis: Pathology Beyond the Skin
Denis Jullien, MD, PhD

IL-17a Inhibition in Psoriasis Therapy:
State of the Art

Ulrich Mrowietz, MD 

Treating to Target in Psoriasis:
What Is the Target?
Richard Langley, MD, FRCPC

Evidence into Action: Case Discussions
Craig Leonardi, MD

Panel Discussion and Conclusion
Craig Leonardi, MD 

*Supported by an Independent Educational Sponsorship from Eli Lilly

Novartis Symposium

"Expanding treatment horizons for patients with psoriasis and psoriatic arthritis"

16:30 - 18:00 - Amphitheatre Bleu


1. Welcome and introduction - Hervé Bachelez (Paris, France, chair)
2. Evolving psoriasis treatment options - Sandra Philipp (Berlin, Germany)
3. Current challenges and future propects in hard-to-treat psoriasis - Curdin Conrad (Lausanne, Switzerland)
4. Beyond the skin: Joint involvement in psoriatic disease - Dominique Baeten (Amsterdam, The Netherlands)
5. Sharing best practice with Clinical Cases - All (chair to moderate)
6. Question and answer session - All (chair to moderate)
7. Summary and conclusions - Chair


Welcome and introduction

Kristian Reich

Hamburg, Germany